Emily Rollins - 01 Mar 2024 Form 4 Insider Report for Dolby Laboratories, Inc. (DLB)

Role
Director
Signature
/s/ Daniel Rodriguez as Attorney-in-Fact for Emily Rollins
Issuer symbol
DLB
Transactions as of
01 Mar 2024
Net transactions value
-$80,880
Form type
4
Filing time
05 Mar 2024, 16:37:31 UTC
Previous filing
29 Feb 2024
Next filing
12 Mar 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DLB Class A Common Stock Sale $80,880 -1,000 -12% $80.88 7,493 01 Mar 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held following the reported transaction include 2,952 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.

Remarks:

The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 8, 2023 which was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) in effect at the time of adoption.